BAFNAPH vs GRANULES: Stock Comparison

BAFNAPH vs GRANULES INDIAUpdated 9 Jun 26, 4:08 PM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. BAFNAPH shows a lower P/E, while GRANULES INDIA shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BAFNAPH leads 3; GRANULES leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BAFNAPHGRANULES

Valuation lens

What price are you paying?

Market CapContext only
₹702 Cr
₹21,073 Cr
P/E RatioBAFNAPH has the lower reading
0x
31.03x
P/B RatioBAFNAPH has the lower reading
0x
4.08x
EPSGRANULES has the higher reading
₹0.03
₹2.9
Book ValueContext only
₹40.64
₹205.21
Dividend YieldGRANULES has the higher reading
0%
0.21%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹21,073 Cr vs ₹702 Cr
P/E Ratio
BAFNAPH has a lower P/E
0x vs 31.03x
P/B Ratio
BAFNAPH has a lower P/B
0x vs 4.08x
EPS
GRANULES has higher earnings per share
₹2.9 vs ₹0.03
Dividend Yield
GRANULES has a higher dividend yield
0.21% vs 0%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 15.4%
EPS Growth (TTM YoY)
BAFNAPH has faster EPS growth
95% vs 31.3%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
-45.7% vs -82.35%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBAFNAPHGRANULES
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBAFNAPHGRANULES
Live Price₹174.58₹848.3
Day Change-10%-0.65%
Volume2.84 L11.73 L
52-Week High₹213.36₹910
52-Week Low₹94.77₹507.3
Distance from 52W High-18.18%-6.78%

Valuation

MetricBAFNAPHGRANULES
Market Cap₹702 Cr₹21,073 Cr
P/E Ratio0x31.03x
P/B Ratio0x4.08x
EPS₹0.03₹2.9
Book Value₹40.64₹205.21
Dividend Yield0%0.21%

Growth

MetricBAFNAPHGRANULES
Revenue Growth (TTM YoY)15.4%22.8%
EPS Growth (TTM YoY)95%31.3%
Qtr Sales Growth-82.35%-45.7%
Qtr Profit Growth-99.32%-60.13%

Profitability & Leverage

MetricBAFNAPHGRANULES
ROE11.54%11.7%
ROCE11.12%12.47%
Net Margin7.37%11.15%
Operating Margin9.71%16.76%
Debt to Equity0.39x0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBAFNAPHGRANULES
Promoter Holding75%37.67%
FII Holding9.34%17.5% 2.19 pp
DII Holding0%16.11% 0.9 pp
Public Holding15.66%28.38% 1.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BAFNAPH and GRANULES INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.